Weight-Loss shot tested as potential breakthrough for dual diagnosis of schizophrenia and alcoholism
Disease control
Recruiting now
This study is testing whether a weekly injection called tirzepatide, currently used for diabetes and weight loss, can help reduce heavy alcohol use in people who also have schizophrenia. About 108 participants will receive either the real drug or a placebo (dummy injection) for 2…
Phase: PHASE2 • Sponsor: Anders Fink-Jensen, MD, DMSci • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC